Direktorat Registrasi ObatValid

AMLODIPINE BESILATE

by '-'

BPOM Number: GKL1739203510B1
Approved: 10 January 2025
Expiry: 9 May 2024
Form: Tablet

About This Registration

AMLODIPINE BESILATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1739203510B1. Its current registration status is Valid, with the licence valid until 9 May 2024. The product is registered to MEGA LIFESCIENCES INDONESIA and manufactured by MEGA LIFESCIENCES INDONESIA - INDONESIA. BPOM first approved this registration in August 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MEGA LIFESCIENCES INDONESIA
Kota Jakarta Pusat, DKI Jakarta, Indonesia
NPWP: 025749474047000
owner
View profile →

Manufacturing Sites

MEGA LIFESCIENCES INDONESIA - INDONESIA
KAB. BOGOR
primary
View profile →

Market Intelligence

Owner Portfolio: MEGA LIFESCIENCES INDONESIA holds 104 BPOM registrations
Manufacturer Scale: MEGA LIFESCIENCES INDONESIA - INDONESIA produces 83 registered products
Registration Age: Registered for 5 years
Expiry Status: Expired 846 days ago

FDA Cross-Reference

via openFDA

Generic Name: AMLODIPINE BESYLATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?